undamentalytics Newsletter
Sign in

Pavmed Inc. revenue

Pavmed Inc.'s revenue was $71,000 in fiscal 2025, down 97.6% on the year before. Since fiscal 2021 ($500,000) it has grown at a compound -38.6% a year. Over the last twelve months it was $112,000.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue5003772,5003,00071112
Growth on the year before—−24.6%+563.1%+20.0%−97.6%—
Gross profit−85−3,237−3,920−1,840−147−247
Gross margin−17.0%——−61.3%——

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Pavmed Inc. $112,000 -89.0% -49.6%
Phaos Technology Holdings (cayman) Ltd $102,806 -18.2% —
Nexalin Technology, Inc. $217,155 24.2% -30.6%
Qtrex Quantum Ltd. $289,000 — —
Cuprina Holdings (cayman) LTD $38,204 5.6% —
Itonic Holdings Ltd $523,031 16.7% —

Compare with peers

Head to head: PAVM vs POASNXL vs PAVMPAVM vs QTEXCUPR vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pavmed Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pavmed Inc.